Financhill
Sell
30

XGN Quote, Financials, Valuation and Earnings

Last price:
$6.18
Seasonality move :
12.88%
Day range:
$5.93 - $6.26
52-week range:
$2.67 - $12.23
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.97x
P/B ratio:
7.73x
Volume:
349.4K
Avg. volume:
312.5K
1-year change:
23.31%
Market cap:
$140.3M
Revenue:
$55.6M
EPS (TTM):
-$0.93

Earnings Data

Next earnings date for XGN
Mar 10
2026
Most recent earnings per share
-$0.31
Missed by $0.15
(Nov 4/2025)
Consensus Estimate
-$0.16
(Nov 4/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

XGN Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/10/2026 Q4 $17.3M -- -- -$0.17 --
11/04/2025 Q3 $16.9M $17.2M -$0.31 -$0.16 -$0.15
07/29/2025 Q2 $16.3M $17.2M -$0.21 -$0.15 -$0.06
05/05/2025 Q1 $14.6M $15.5M -$0.20 -$0.21 $0.00
03/11/2025 Q4 $13.9M $13.7M -$0.20 -$0.24 $0.04
11/12/2024 Q3 $13.6M $12.5M -$0.28 -$0.29 $0.01
08/05/2024 Q2 $13.1M $15.1M -$0.16 -$0.35 $0.18
05/13/2024 Q1 $13.1M $14.4M -$0.19 -$0.35 $0.16
03/18/2024 Q4 $11.6M $13.8M -$0.31 -$0.43 $0.12
11/13/2023 Q3 $10.3M $13.4M -$0.31 -$0.49 $0.19
08/07/2023 Q2 -- $14.1M -$0.28 -- --
05/15/2023 Q1 -- $11.2M -$0.44 -- --
03/20/2023 Q4 -- $12.8M -$0.83 -- --
11/14/2022 Q3 -- $14.7M -$0.47 -- --
08/04/2022 Q2 -- $7.6M -$0.86 -- --
05/11/2022 Q1 -- $10.4M -$0.60 -- --
03/22/2022 Q4 -- $12.7M -$0.42 -- --
11/10/2021 Q3 -- $12.3M -$0.42 -- --
08/09/2021 Q2 -- $12.8M -$0.38 -- --
05/11/2021 Q1 -- $10.6M -$0.48 -- --
03/16/2021 Q4 -- $12.7M -$0.27 -- --
11/10/2020 Q3 -- $10.8M -$0.34 -- --
07/28/2020 Q2 -- $8.9M -$0.27 -- --
05/11/2020 Q1 -- $9.6M -$0.44 -- --
03/25/2020 Q4 -- $10.2M -$0.27 -- --
11/12/2019 Q3 -- $10.4M -$11.29 -- --
06/30/2019 Q2 -- $10.5M -$0.41 -- --
03/31/2019 Q1 -- $9.3M -$0.40 -- --
12/31/2018 Q4 -- $9.6M -$0.72 -- --
09/30/2018 Q3 -- $8.2M -$0.38 -- --
06/30/2018 Q2 -- $7.8M -$0.37 -- --
03/31/2018 Q1 -- $6.8M -$0.44 -- --
12/31/2015 Q4 -- $4.4M -$0.26 -- --

Exagen, Inc. Earnings Questions

  • How Much did Exagen, Inc. Generate in Revenue Last Quarter?

    Exagen, Inc. reported $17.2M worth of top line sales in its most recent quarter.

  • Did Exagen, Inc. Beat Earnings Last Quarter?

    Exagen, Inc. announced earnings per share of -$0.31 which represents a miss of analyst forecast a -$0.16 per share.

  • Is Exagen, Inc. Profitable?

    Exagen, Inc. reported $10.1M that represents $0.44 per share over the last quarter.

  • What is the Analyst Consensus for Exagen, Inc. EPS Next Year?

    Exagen, Inc.'s earnings are forecast to decrease from -$0.83 per share to -$0.87 per share next year representing a decrease of -1.16%.

  • When is Exagen, Inc.'s Earnings Date?

    Exagen, Inc.'s next earnings date is March 10, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock